SRV Yhtiöt Oyj (LON:0JBJ)
4.990
-0.090 (-1.77%)
At close: Oct 23, 2025
SRV Yhtiöt Oyj Revenue
SRV Yhtiöt Oyj had revenue of 159.70M EUR in the quarter ending September 30, 2025, a decrease of -12.97%. This brings the company's revenue in the last twelve months to 699.01M, down -2.70% year-over-year. In the year 2024, SRV Yhtiöt Oyj had annual revenue of 745.81M with 22.26% growth.
Revenue (ttm)
699.01M EUR
Revenue Growth
-2.70%
P/S Ratio
0.12
Revenue / Employee
920.97K EUR
Employees
759
Market Cap
74.15M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 745.81M | 135.78M | 22.26% |
| Dec 31, 2023 | 610.03M | -160.05M | -20.78% |
| Dec 31, 2022 | 770.08M | -162.48M | -17.42% |
| Dec 31, 2021 | 932.55M | -42.98M | -4.41% |
| Dec 31, 2020 | 975.53M | -85.42M | -8.05% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 198.54B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| AstraZeneca | 41.24B |
| HSBC Holdings | 41.03B |
| Rio Tinto Group | 39.22B |
| GSK plc | 31.63B |
| British American Tobacco p.l.c. | 25.60B |